Differentiated & Simplified PrEP for HIV Prevention - Heather-Marie Schmidt

APACC 2022

New Antiretroviral Drugs-Formulations for the Treatment of PLWH and for Prevention of HIV - Jennifer Hoy

APACC 2022

Clinical Implications of Cabotegravir Plasma Levels - Charles Flexner, MD

International Workshop on Clinical Pharmacology of HIV, Hepatitis, and Other Antiviral Drugs 2022

DDIs Relevant for COVID-19 Therapeutic Agents & Implementation Challenges - Fiona Marra, MPharm, MSc

International Workshop on Clinical Pharmacology of HIV, Hepatitis, and Other Antiviral Drugs 2022

Emerging Strategies for Treating and Preventing Monkeypox 2022 - Ruth Byrne, MD

International Workshop on Clinical Pharmacology of HIV, Hepatitis, and Other Antiviral Drugs 2022

Long-acting Cabotegravir Pharmacokinetics With and Without Oral Lead-in for HIV PrEP - Kelong Han

International Workshop on Clinical Pharmacology of HIV, Hepatitis, and Other Antiviral Drugs 2022

The Non-adherent Patient A Good or Bad Candidate for CAB+RPV - Jose Castillo-Mancilla, MD

International Workshop on Clinical Pharmacology of HIV, Hepatitis, and Other Antiviral Drugs 2022

CabotegravirRilpivirine Failures Despite Adherence Slides - Jose Castillo-Mancilla, MD

International Workshop on Clinical Pharmacology of HIV, Hepatitis, and Other Antiviral Drugs 2022

Deep Learning Ensemble Classifier to Predict Drug-Drug Interaction - Thao Pham

International Workshop on Clinical Pharmacology of HIV, Hepatitis, and Other Antiviral Drugs 2022

Islatravir Toxicity Slides - Charles Flexner, MD

International Workshop on Clinical Pharmacology of HIV, Hepatitis, and Other Antiviral Drugs 2022

Lenacapavir Considerations - Jonathan Schapiro, MD

International Workshop on Clinical Pharmacology of HIV, Hepatitis, and Other Antiviral Drugs 2022

Optimization of Pharmacology Studies and DDIs in Pregnant and Lactating Individuals - Angela Colbers, PhD

International Workshop on Clinical Pharmacology of HIV, Hepatitis, and Other Antiviral Drugs 2022

Pharmacology Pearls for Managing Absorption and Swallowing Difficulties - Saye Khoo, MD, PhD

International Workshop on Clinical Pharmacology of HIV, Hepatitis, and Other Antiviral Drugs 2022

Strategies to Improve Delivery to Reservoirs as Targets for Long-Acting Antivirals - Adeniyi Olagunju, BPharm, MRes, PhD

International Workshop on Clinical Pharmacology of HIV, Hepatitis, and Other Antiviral Drugs 2022

Nutritionists Perspective Lifestyle and Behavioral Structured Interventions-Shira Zelber-Sagi,BSc, RD, PhD slides

Innovations in NAFLD Care Workshop 2022

Pushing for Weight Management Bariatric Interventions Benefits and Considerations-Jörn Schattenberg, MD slides

Innovations in NAFLD Care Workshop 2022

Is NAFLDNASH a Public Health Challenge in 2022-Zobair M. Younossi, MD, MPH, FACG, FACP, AGAF, FAASLD slides

Innovations in NAFLD Care Workshop 2022

The Central Role of Primary Care in the NASH Epidemic Opportunities and Challenges-Helen Jarvis,MD slides

Innovations in NAFLD Care Workshop 2022

The Liver-Heart Axis – Does NASH Drive Cardiovascular Disease- Sven Francque, MD, PhD slides

Innovations in NAFLD Care Workshop 2022

Use of Intelligent Liver Function Testing in General Practice-John Dillon, MB,BS,MD,MRCP(UK),FRCP(Edinburgh) slide

Innovations in NAFLD Care Workshop 2022

Integrating Non-Invasive Tests for NAFLD in Clinical Practice Outside the Liver Space - Which Test and at What Level-Alina Allen, MD slides

Innovations in NAFLD Care Workshop 2022

How to Use Diabetes Drugs for Liver Benefit in Patients with NAFLD, Kenneth Cusi, MD, FACP, FACE slides

Innovations in NAFLD Care Workshop 2022

Liver-Directed Drugs in the Pipeline for Fibrotic NASH,Stephen Harrison, M.D, FACP, FAASLD Col (ret.) slides

Innovations in NAFLD Care Workshop 2022

Pharmacotherapy for Obesity - Improving Body Weight and NAFLD, Naim Alkhouri, MD slides

Innovations in NAFLD Care Workshop 2022